NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
GLPG5101. Dr Marie José Kersten, Professor of Haematology at Amsterdam University Medical Centres, Netherlands, presented promising...
Women who experience premature ovarian insufficiency (POI) before the age of 40 are more likely to...
In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...
New research presented at the 67th American Society of Hematology (ASH) Annual Meeting in December 2025...
First results from the phase 3 GIMEMA ALL2820 trial suggest chemotherapy-free combination treatment outperforms a combination...
Patients newly diagnosed with acute myeloid leukaemia (AML) who are eligible for intensive chemotherapy fare significantly...
BTK. Also presented at the ASH Annual Meeting were the results from the first randomised phase...
Video-observed therapy (VOT) is among the measures needed to enhance tuberculosis (TB) care in Ireland, heard...
Hidradenitis suppurativa (HS), also known as Verneuil disease, acne inversa, or terminal hair dissecting folliculitis, is...
Haemophilia is an inherited X-linked bleeding disorder which affects approximately 1,125,000 individuals globally. Haemophilia...
Patients. Astellas Pharma recently announced results from the open-label, randomised controlled phase 3 EV-302 clinical trial...
While most doctors in primary care and medical specialties are experienced in the management of uncomplicated...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT